Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
Jamaica Szeliga
ID:
1b834eb3-2619-30fb-68c4
/
Claimed Record
/
Organization:
Seyfarth Shaw LLP
Published Works
12 articles
“Rigged” Pricing, Contracting and Rebate “Schemes,” and Drug Pricing “Shell Games:” FDA Commissioner Scott Gottlieb Lets Loose on the U.S. Biosimilar Market While Offering Peek at New Policies
BioLoquitur ·
March 19, 2018
cite
Webinar: Biosimilar Litigation and Your BPCIA Compliance: Key Strategies In Light of AbbVie v. Boehringer
BioLoquitur ·
February 20, 2018
cite
Now Available! Seyfarth Shaw’s Hatch-Waxman and Biosimilars Litigation: 2017 Year-in-Review
BioLoquitur ·
February 8, 2018
cite
“Tax Cut and Jobs Act” H.R. 1 Passes House Of Representatives: Provisions To Watch
BioLoquitur ·
November 20, 2017
cite
Sandoz v. Amgen: The Latest in Biosimilar “Dances”
BioLoquitur ·
June 28, 2017
cite
Previous
1
2
3
Next
Practice Areas
Health Care and Life Sciences
Intellectual Property
Jurisdictions
North America
United States
